DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.

Verily, formerly Google Life Sciences, plans on enrolling 10,000 participants in a study incorporating the latest technology for data collection on how individuals can lead their healthiest lives.

As a Bronze Sponsor of the National Rx Drug Abuse and Heroin Summit, Proove® Biosciences, Inc. announces the first-ever peer-reviewed published clinical study analyzing genetics, environmental, and lifestyle factors to accurately predict prescription opioid abuse.

electroCore, a neuroscience and technology company dedicated to improving patient outcomes through technological advancement, announced today that the U.S. Food and Drug Administration (FDA) released the use of gammaCore® (non-invasive vagus nerve stimulator) for the acute treatment of pain associated with episodic cluster headache in adult patients. gammaCore transmits a mild electrical stimulation to the vagus nerve through the skin, resulting in a reduction of pain. This is the first FDA product release for electroCore in the U.S.

Verily, a subsidiary of Alphabet, recently introduced its newly developed Verily Study Watch. This wearable was made more for the clinical research rather than the consumer and offers continuous monitoring, making collecting data as easy as ever.

A study, published in Mobile Media & Communication, found mobile health interventions (mHealth) improve access to care and patient engagement in patients with HIV.

The Centers for Disease Control and Prevention (CDC) has officially recognized virtual diabetes prevention program (DPP) developed by Noom. First introduced in 2013, the program was submitted for recognition when the CDC began accepting mobile and online DPP applications in 2015.

If the U.S. Department of Veterans Affairs (VA) decides to ditch its in-house electronic health record (EHR) system for a commercial product, Cerner would be the best vendor candidate, according to a report from Black Book.